トップページ > 研究組織一覧 > 分野・独立ユニットグループ > 新領域創成プロジェクトグループ > 希少がん研究分野 > 細胞株の提供実績

細胞株の提供実績

2021年3月31日 NCC-SS1-C1、NCC-SS2-C1、NCC-SS3-C1、NCC-SS4-C1

滑膜肉腫の細胞株を、がん研究センター研究所 がん治療学研究分野荻原 秀明先生へ提供しました。

文献
Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15. PubMed PMID: 29450702.

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, Yoshida A, Kawai A,Kondo T. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018 May;54(5):392-399. doi: 10.1007/s11626-018-0237-7. Epub 2018 Apr 6. PubMed PMID: 29626278.

Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Iwata S, Yoshida A,Kawai A, Kondo T. Establishment and Characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma. Hum Cell. 2020 Apr 9. doi:10.1007/s13577-020-00354-6. Epub ahead of print. PMID: 32274656.

Tsuchiya R, Yoshimatsu Y, Noguchi R, Ono T, Sei A, Takeshita F, Sugaya J, Iwata S, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-SS4-C1: a novel patient-derived cell line of synovial sarcoma. Hum Cell. 2021 Feb 20. doi: 10.1007/s13577-021-00509-z. Epub ahead of print. PMID: 33611700.

 

2021年1月21日 NCC-MPNST1-C1、NCC-MPNST2-C1、NCC-MPNST3-C1、NCC-MPNST3-X2-C1、NCC-MPNST4-C1、NCC-MPNST5-C1

悪性末梢神経鞘腫瘍の細胞株を、がん研究センター研究所 がん治療学研究分野荻原 秀明先生へ提供しました。

文献
Oyama R, Kito F, Takahashi M, Hattori E, Noguchi R, Takai Y, Sakumoto M, Qiao Z, Toki S, Sugawara M, Tanzawa Y, Kobayashi E, Nakatani F, Iwata S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors. Cancer Cell Int. 2020 Feb 19;20時58分. doi: 10.1186/s12935-020-1128-z. PMID: 32099531; PMCID: PMC7031935.

 

2021年1月15日  NCC-ASPS1-C1、NCC-LMS1-C1 、NCC-LMS2-C1、NCC-PLPS1-C1

胞巣状軟部肉腫、平滑筋肉腫、多形型脂肪肉腫の細胞株を、National Center for Tumor Diseases Heidelbergの Priya Chudasama先生へ提供しました。

文献
Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Fukushima S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma. Hum Cell. 2020 Oct;33(4):1302-1310. doi:10.1007/s13577-020-00382-2. Epub 2020 Jul 10. PMID: 32648033.

Sakumoto M, Takahashi M, Oyama R, Takai Y, Kito F, Shiozawa K, Qiao Z, Yoshida A, Endo M, Kawai A, Kondo T. Establishment and proteomic characterization of NCC-LMS1-C1, a novel cell line of primary leiomyosarcoma of the bone. Jpn J Clin Oncol. 2017 Oct 1;47(10):954-961. doi:10.1093/jjco/hyx096. PubMed PMID:28981730.

Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of NCC-LMS2-C1-a novel patient- derived cancer cell line of leiomyosarcoma. Hum Cell. 2021 Jan;34(1):279-288. doi:10.1007/s13577-020-00443-6. Epub 2020 Oct 1. PMID: 33001379.

Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of NCC-PLPS1-C1, a novel patient- derived cell line of pleomorphic liposarcoma. Hum Cell. 2020 Nov 17. doi:10.1007/s13577-020-00457-0. Epub ahead of print. PMID: 33205363.

 

2021年1月13日  NCC-UPS1-C1、NCC-UPS2-C1、NCC-MFS1-C1

未分化多形肉腫(UPS)、粘液線維肉腫の細胞株を、岡山大学 整形外科 藤原 智洋先生へ提供しました。

文献
Takai Y, Oyama R, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Nakajima K, Takahashi M, Yoshida A, Setsu N, Kobayashi E, Kawai A, Kondo T. Establishment and characterization of cell line of undifferentiated pleomorphic sarcoma. Tiss Cult Res Comm.2017;36(5)41-48.

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T.  Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1, derived from a patient with undifferentiated pleomorphic sarcoma. In Vitro Cell Dev Biol Anim. 2018 Mar;54(3):257-263. doi: 10.1007/s11626-018-0229-7. Epub 2018 Jan 22. PubMed PMID: 29359268.

Kito F, Oyama R, Sakumoto M, Shiozawa K, Qiao Z, Toki S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma. Hum Cell. 2019 Apr;32(2):214-222. doi: 10.1007/s13577-018-00233-1. Epub 2019 Feb 8. PubMed PMID: 30737712.

 

2020年12月7日  NCC-GCTB1-C1

骨巨細胞腫の細胞株を、九州大学 形態機能病理学の戸田 雄先生へ提供しました。

文献
Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of NCC-GCTB1-C1: a novel patient-derived cancer cell line of giant cell tumor of bone. Hum Cell. 2020 Aug 19. doi: 10.1007/s13577-020-00415-w. Epub ahead of print. PMID: 32815117

 

2020年11月23日  NCC-CDS1-X1-C1、NCC-CDS1-X3-C1、NCC-CDS2-C1

CIC-DUX4陽性小細胞肉腫の細胞株をSt. Jude Children's Research Hospital のAnang Shealat先生へ提供しました。

文献
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486

Yoshimatsu Y, Noguchi R, Tsuchiya R, Kito F, Sei A, Sugaya J, Nakagawa M, Yoshida A, Iwata S, Kawai A, Kondo T. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma. Hum Cell. 2020 Apr;33(2):427-436.

 

2020年11月21日  NCC-CDS1-X1-C1、NCC-CDS2-C1

CIC-DUX4陽性小細胞肉腫の細胞株をUniversity of Miami Health のJosiane Eid先生へ提供しました。

文献
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486

Yoshimatsu Y, Noguchi R, Tsuchiya R, Kito F, Sei A, Sugaya J, Nakagawa M, Yoshida A, Iwata S, Kawai A, Kondo T. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma. Hum Cell. 2020 Apr;33(2):427-436.

 

2020年11月19日  NCC-MFS1-C1、NCC-MFS2-C1

粘液線維肉腫の細胞株を、札幌医科大学 病理学第一講座の村田 憲治先生へ提供しました。

文献
Kito F, Oyama R, Sakumoto M, Shiozawa K, Qiao Z, Toki S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma. Hum Cell. 2019 Apr;32(2):214-222. doi: 10.1007/s13577-018-00233-1. Epub 2019 Feb 8. PubMed PMID: 30737712.

Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of NCC-MFS2-C1: a novel patient-derived cancer cell line of myxofibrosarcoma. Hum Cell. 2020 Sep 1. doi: 10.1007/s13577-020-00420-z. Epub ahead of print. PMID: 32870449.

 

2020年9月23日 NCC-aRMS1-C1

胞巣型横紋筋肉腫の細胞株をChildren's Cancer Therapy Development InstituteのCharles Keller先生へ提供しました。

文献
Sin Y, Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Ono T, Toki S, Kobayashi E, Arakawa A, Sugiyama M, Yoshida A, Kawai A, Kondo T. Establishment and characterization of a novel alveolar rhabdomyosarcoma cell line, NCC-aRMS1-C1. Human Cell.2020 Jul 26. doi: 10.1007/s13577-020-00403-0. Epub ahead of print. PMID: 32715445.

 

2020年8月13日 NCC-CDS2-C1

CIC-DUX4陽性小細胞肉腫の細胞株をHudson Alpha Institute for BiotechnologyのLe Su先生へ提供しました。

文献
Yoshimatsu Y, Noguchi R, Tsuchiya R, Kito F, Sei A, Sugaya J, Nakagawa M, Yoshida A, Iwata S, Kawai A, Kondo T. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma. Hum Cell. 2020 Apr;33(2):427-436.

 

2020年7月31日 NCC-ssRMS1-C1

横紋筋肉腫の細胞株をSt. Jude Children’s Research HospitalのMichael Dyer先生へ提供しました。

文献
Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Iwata S, Sugiyama M,Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-ssRMS1-C1: a novel patient-derived spindle-cell/sclerosing rhabdomyosarcoma cell line. Hum Cell. 2020 Apr 16. doi: 10.1007/s13577-020-00359-1. Epub ahead of print. PMID: 32300959.

 

2020年6月22日 NCC-SS1-C1、NCC-SS2-C1、NCC-SS3-C1

滑膜肉腫の細胞株をSeoul National University HospitalのDo Wook Kim先生へ提供しました。

文献
Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15. PubMed PMID: 29450702.

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, Yoshida A, Kawai A,Kondo T. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018 May;54(5):392-399. doi: 10.1007/s11626-018-0237-7. Epub 2018 Apr 6. PubMed PMID: 29626278.

Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Iwata S, Yoshida A,Kawai A, Kondo T. Establishment and Characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma. Hum Cell. 2020 Apr 9. doi:10.1007/s13577-020-00354-6. Epub ahead of print. PMID: 32274656.

 

2020年6月9日 NCC-SS3-C1、NCC-ASPS1-C1

滑膜肉腫、胞巣状軟部肉腫の細胞株を、がん研究会 がん化学療法センター分子薬理部の旦慎吾先生へ提供しました。

文献
Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Iwata S, Yoshida A,Kawai A, Kondo T. Establishment and Characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma. Hum Cell. 2020 Apr 9. doi:10.1007/s13577-020-00354-6. Epub ahead of print. PMID: 32274656.

NCC-ASPS1-C1 論文投稿中

 

2020年4月1日 NCC-UPS2-C1、NCC-UPS1-C1、NCC-LMS1-C1、NCC-DDLS1-C1、NCC-MLS1-C1

未分化多形肉腫(UPS)、脱分化型軟骨肉腫、平滑筋肉腫、脱分化型脂肪肉腫、粘液型脂肪肉腫の細胞株を、奈良県立医科大学 泌尿器科 三宅 牧人先生へ提供しました。

文献
Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T.  Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1, derived from a patient with undifferentiated pleomorphic sarcoma. In Vitro Cell Dev Biol Anim. 2018 Mar;54(3):257-263. doi: 10.1007/s11626-018-0229-7. Epub 2018 Jan 22. PubMed PMID: 29359268.

Takai Y, Oyama R, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Nakajima K, Takahashi M, Yoshida A, Setsu N, Kobayashi E, Kawai A, Kondo T. Establishment and characterization of cell line of undifferentiated pleomorphic sarcoma. Tiss Cult Res Comm.2017;36(5)41-48.

Sakumoto M, Takahashi M, Oyama R, Takai Y, Kito F, Shiozawa K, Qiao Z, Yoshida A, Endo M, Kawai A, Kondo T. Establishment and proteomic characterization of NCC-LMS1-C1, a novel cell line of primary leiomyosarcoma of the bone. Jpn J Clin Oncol. 2017 Oct 1;47(10):954-961. doi: 10.1093/jjco/hyx096. PubMed PMID:28981730.

NCC-DDLS1-C1 論文投稿中
NCC-MLS1-C1 論文投稿中

 

2020年3月5日 NCC-UPS2-C1、NCC-UPS1-C1、NCC-UPS1-X3-C1、NCC-dCS1-C1、NCC-CCS1B-X2-C1、NCC-CCS1-X4-C1、NCC-CCS1B-C1、NCC-CDS1-X1-C1、NCC-CDS1-X3-C、NCC-CDS2-C1

未分化多形肉腫(UPS)、脱分化型軟骨肉腫、明細胞肉腫、CIC-DUX4陽性小細胞肉腫の細胞株を、大阪国際がんセンター 整形外科 若松 透先生へ提供しました。

文献
Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T.  Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1, derived from a patient with undifferentiated pleomorphic sarcoma. In Vitro Cell Dev Biol Anim. 2018 Mar;54(3):257-263. doi: 10.1007/s11626-018-0229-7. Epub 2018 Jan 22. PubMed PMID: 29359268.

Takai Y, Oyama R, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Nakajima K, Takahashi M, Yoshida A, Setsu N, Kobayashi E, Kawai A, Kondo T. Establishment and characterization of cell line of undifferentiated pleomorphic sarcoma. Tiss Cult Res Comm.2017;36(5)41-48.

Kito F, Oyama R, Takahashi M, Shiozawa K, Sakumoto M, Yoshida A, Setsu N, Kobayashi E, Kawai A, Kondo T. Establishment and characterization of a patient-derived cancer model of undifferentiated pleomorphic sarcoma. Tiss. Cult. Res. Commun. 2018 37: 1–13

Oyama R, Kito F, Takahashi M, Sakumoto M, Shiozawa K, Qiao Z, Noguchi R, Kubo T, Toki S, Nakatani F, Yoshida A, Kawai A, Kondo T. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1. Hum Cell. 2019 Apr;32(2):202-213. doi: 10.1007/s13577-018-00232-2. PubMed PMID: 30737713.

Sakumoto M, Oyama R, Takahashi M, Takai Y, Kito F, Shiozawa K, Qiao Z, Endo M, Yoshida A, Kawai A, Kondo T. Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines. In Vitro Cell Dev Biol Anim. 2018 Feb;54(2):163-176. doi: 10.1007/s11626-017-0207-5. Epub 2017 Dec 1. PubMed PMID: 29197033.

Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486

Yoshimatsu Y, Noguchi R, Tsuchiya R, Kito F, Sei A, Sugaya J, Nakagawa M, Yoshida A, Iwata S, Kawai A, Kondo T. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma. Hum Cell. 2020 Apr;33(2):427-436.

 

2020年2月26日 NCC-ESOS1-C1、NCC-OS2-C1、NCC-CDS1-X1-C1、NCC-CDS1-X3-C、NCC-CDS2-C1

骨外性骨肉腫、骨肉腫、CIC-DUX4陽性小細胞肉腫の細胞株を、京都大学 物質-細胞統合システム拠点(iCeMS)小松 葵先生へ提供しました。

文献
Kito F, Oyama R, Noguchi R, Hattori E, Sakumoto M, Endo M, Kobayashi E, Yoshida A, Kawai A, Kondo T. Establishment and characterization of novel patient-derived extraskeletal osteosarcoma cell line NCC-ESOS1-C1. Hum Cell. 2019 Oct 17. doi: 10.1007/s13577-019-00291-z. PubMed PMID: 31625124. 

Kito F, Oyama R, Sakumoto M, Takahashi M, Shiozawa K, Qiao Z, Sakamoto H, Hirose T, Setsu N, Yoshida A, Kawai A, Kondo T. Establishment and characterization of novel patient-derived osteosarcoma xenograft and cell line. In Vitro Cell Dev Biol Anim. 2018 Aug;54(7):528-536. doi: 10.1007/s11626-018-0274-2. Epub 2018 Jun 25. PubMed PMID: 29943355

Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486

Yoshimatsu Y, Noguchi R, Tsuchiya R, Kito F, Sei A, Sugaya J, Nakagawa M, Yoshida A, Iwata S, Kawai A, Kondo T. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma. Hum Cell. 2020 Apr;33(2):427-436.

 

2020年2月26日 NCC-CCS1B-C1、NCC-DFSP1-C1、NCC-ES1-C1、NCC-DFSP2-C1、NCC-CDS2-C1、NCC-MLS1-C1

明細胞肉腫、隆起性皮膚線維肉腫、ユーイング腫瘍、CIC遺伝子再構成肉腫、粘液型脂肪肉腫の細胞株を、がん研究会 がん化学療法センター分子薬理部の旦慎吾先生へ提供しました。

文献
Sakumoto M, Oyama R, Takahashi M, Takai Y, Kito F, Shiozawa K, Qiao Z, Endo M, Yoshida A, Kawai A, Kondo T. Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines. In Vitro Cell Dev Biol Anim. 2018 Feb;54(2):163-176. doi: 10.1007/s11626-017-0207-5. Epub 2017 Dec 1. PubMed PMID: 29197033.

Oyama R, Kito F, Qiao Z, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T. Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1. In Vitro Cell Dev Biol Anim. 2019 Jan;55(1):62-73. doi: 10.1007/s11626-018-0305-z. PubMed PMID: 30411273.

Oyama R, Kito F, Qiao Z, Sakumoto M, Noguchi R, Takahashi M, Toki S, Tanzawa Y, Yoshida A, Kawai A, Kondo T. Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1. In Vitro Cell Dev Biol Anim. 2018 Dec;54(10):770-778. doi: 10.1007/s11626-018-0302-2. Epub 2018 Oct 15. PubMed PMID: 30324244.

Yoshimatsu Y, Noguchi R, Tsuchiya R, Kito F, Sei A, Sugaya J, Nakagawa M, Yoshida A, Iwata S, Kawai A, Kondo T. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma. Hum Cell. 2020 Apr;33(2):427-436.

 

2020年2月14日 NCC-DDLS1-C1

脱分化型脂肪肉腫の細胞株を、がん研究センター研究所 分子発がん研究ユニットの土屋 直人先生へ提供しました。

文献    NCC-DDLS1-C1 論文投稿中

 

2020年2月12日 NCC-ES1-C1、NCC-CCS1B-C1、NCC-CDS2-C1、NCC-SS1-C1、NCC-DFSP1-C1、NCC-DFSP2-C1

ユーイング腫瘍、明細胞肉腫、CIC-DUX4陽性小細胞肉腫、滑膜肉腫、隆起性皮膚線維肉腫の細胞株を、がん研究センター鶴岡連携研究拠点 がんメタボロミクス研究室の横山明彦先生へ提供しました。

文献
Oyama R, Kito F, Qiao Z, Sakumoto M, Noguchi R, Takahashi M, Toki S, Tanzawa Y, Yoshida A, Kawai A, Kondo T. Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1. In Vitro Cell Dev Biol Anim. 2018 Dec;54(10):770-778. doi: 10.1007/s11626-018-0302-2. Epub 2018 Oct 15. PubMed PMID: 30324244.

Sakumoto M, Oyama R, Takahashi M, Takai Y, Kito F, Shiozawa K, Qiao Z, Endo M, Yoshida A, Kawai A, Kondo T. Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines. In Vitro Cell Dev Biol Anim. 2018 Feb;54(2):163-176.

Yoshimatsu Y, Noguchi R, Tsuchiya R, Kito F, Sei A, Sugaya J, Nakagawa M, Yoshida A, Iwata S, Kawai A, Kondo T. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma. Hum Cell. 2020 Jan 2. doi: 10.1007/s13577-019-00312-x. PubMed PMID: 31898195

Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15.

Oyama R, Kito F, Qiao Z, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T. Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1. In Vitro Cell Dev Biol Anim. 2019 Jan;55(1):62-73. doi: 10.1007/s11626-018-0305-z. PubMed PMID: 30411273.

 

2020年2月10日 NCC-MPNST1-C1、NCC-MPNST2-C1、NCC-MPNST3-C1、NCC-MPNST3-X2-C1、NCC-MPNST4-C1、NCC-MPNST5-C1

悪性末梢神経鞘腫瘍の細胞株を、札幌医科大学整形外科の江森誠人先生へ提供しました。

文献
MPNST 論文投稿中

 

2020年1月27日 NCC-CDS2-C1

CIC-DUX4陽性小細胞肉腫の細胞株を、Lausanne University HospitalのArnaud Bakaric博士へ提供しました。

文献
Yoshimatsu Y, Noguchi R, Tsuchiya R, Kito F, Sei A, Sugaya J, Nakagawa M, Yoshida A, Iwata S, Kawai A, Kondo T. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma. Hum Cell. 2020 Jan 2. doi: 10.1007/s13577-019-00312-x. PubMed PMID: 31898195

 

2020年1月7日 NCC-CDS-X1‐C1、NCC-CDS1-X3-C1

CIC-DUX4陽性小細胞肉腫の細胞株を、Hospital del Mar Medical Research InstituteのInma Hernández-Muñoz博士へ提供しました。

文献
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486.

 

2019年12月17日 NCC-pRMS1-C1

横紋筋肉腫の細胞株を、University of WashingtonのEleanor Chen博士へ提供しました。

文献  
Oyama R, Takahashi M, Kito F, Sakumoto M, Takai Y, Shiozawa K, Qiao Z, Toki S, Tanzawa Y, Toshida A, Kawai A, Kondo T. Establishment and characterization of patient-derived pleomorphic rhabdomyosarcoma models.Tiss. Cult. Res. Commun. In press

 

2019年12月10日 NCC-CDS-X1‐C1、NCC-CDS1-X3-C1

CIC-DUX4陽性小細胞肉腫の細胞株を、Provincial Health Services AuthorityのDimitrow Theolina博士へ提供しました。

文献
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486.

 

2019年12月2日 NCC-CDS2-C1

CIC-DUX4陽性小細胞肉腫の細胞株を、University of CaliforniのRoss Okimoto博士へ提供しました。

文献
Yoshimatsu Y, Noguchi R, Tsuchiya R, Kito F, Sei A, Sugaya J, Nakagawa M, Yoshida A, Iwata S, Kawai A, Kondo T. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma. Hum Cell. 2020 Jan 2. doi: 10.1007/s13577-019-00312-x. PubMed PMID: 31898195

 

2019年11月30日 NCC-CDS-X1‐C1、NCC-CDS1-X3-C1

CIC-DUX4陽性小細胞肉腫の細胞株を、University of MinnesotaのMichael Kyba博士へ提供しました。

文献
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486.

 

2019年11月30日 NCC-CDS-X1‐C1、NCC-CDS1-X3-C1

CIC-DUX4陽性小細胞肉腫の細胞株を、Memorial Sloan Kettering Cancer CenterのAlex Kentsis博士へ提供しました。

文献
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486.

 

2019年11月26日 NCC-UPS1-C1、NCC-UPS1-X3-C1、NCC-UPS2-C1

未分化多型肉腫の細胞株を、Charles University PragueのJirina Bartunkova博士へ提供しました。

文献
Takai Y, Oyama R, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Nakajima K, Takahashi M. Yoshida A, Nokitaka S, Kobayashi E, Kawai A. Kondo T. Establishment and characterization of cell line of undifferentiated pleomorphic sarcoma. Tiss. Cult. Res. Commun. 36: 41–48 (2017)

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T.Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1,derived from a patient with undifferentiated pleomorphic sarcoma. In Vitro Cell Dev Biol Anim. 2018 Mar;54(3):257-263. doi: 10.1007/s11626-018-0229-7. Epub 2018 Jan 22. PubMed PMID: 29359268.

2019年11月25日 NCC-CDS-X1‐C1、NCC-CDS1-X3-C1、NCC-CDS2-C1

CIC-DUX4陽性小細胞肉腫の細胞株を、University Health NetworkのSevera Bunda博士へ提供しました。

文献
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486.

NCC-CDS2-C1 論文投稿中

2019年10月15日 NCC-OS1-X2-C1、NCC-OS2-C1、NCC-ES1-C1、NCC-dCS1-C1、NCC-UPS1-C1、NCC-UPS1-X3-C1、NCC-UPS2-C1、NCC-LMS1-C1、NCC-LMS1-X3-C1、NCC-pRMS1-C1、NCC-pRMS1-X4-C1、NCC-SS1-C1、NCC-SS2-C1、NCC-CCS1B-X2-C1、NCC-CCS1B-C1、NCC-CCS1-X4-C1、NCC-MFS1-C1、NCC-CDS1-X1-C1、NCC-CDS1-X3-C1、NCC-DFSP1-C1、NCC-DFSP2-C1、NCC-MPNST1-C1、NCC-MPNST2-C1、NCC-MPNST3-C1、NCC-MPNST3-X2-C1、NCC-MPNST4-C1、NCC-MPNST5-C1

骨肉腫、ユーイング腫瘍、脱分化型軟骨肉腫、未分化肉腫、平滑筋肉腫、横紋筋肉腫、滑膜肉腫、明細胞肉腫、粘液線維肉腫、CIC-DUX4陽性小細胞肉腫、隆起性皮膚線維肉腫、悪性末梢神経鞘腫瘍、の細胞株を、Broad InstituteのJesse S. Boehm博士へ提供しました。

文献

Kito F, Oyama R, Sakumoto M, Takahashi M, Shiozawa K, Qiao Z, Sakamoto H, Hirose T, Setsu N, Yoshida A, Kawai A, Kondo T. Establishment and characterization of novel patient-derived osteosarcoma xenograft and cell line. In Vitro Cell Dev Biol Anim. 2018 Jun 25. doi: 10.1007/s11626-018-0274-2. PubMed PMID:29943355

Oyama R, Kito F, Qiao Z, Sakumoto M, Noguchi R, Takahashi M, Toki S, Tanzawa Y, Yoshida A, Kawai A, Kondo T. Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1. In Vitro Cell Dev Biol Anim. 2018 Dec;54(10):770-778. doi: 10.1007/s11626-018-0302-2. Epub 2018 Oct 15. PubMed PMID: 30324244.

Oyama R, Kito F, Takahashi M, Sakumoto M, Shiozawa K, Qiao Z, Noguchi R, Kubo T, Toki S, Nakatani F, Yoshida A, Kawai A, Kondo T. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1. Hum Cell. 2019 Feb 8. doi: 10.1007/s13577-018-00232-2. PubMed PMID: 30737713.

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T. Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1, derived from a patient with undifferentiated pleomorphic sarcoma. In Vitro Cell Dev Biol Anim. 2018 Mar;54(3):257-263. doi: 10.1007/s11626-018-0229-7. Epub 2018 Jan 22.

Takai Y, Oyama R, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Nakajima K, Takahashi M, Yoshida A, Setsu N, Kobayashi E, Kawai A, Kondo T. Establishment and characterization of cell line of undifferentiated pleomorphic sarcoma. Tiss Cult Res Comm.2017;36(5)41-48.

Kito F, Oyama R, Takahashi M, Shiozawa K, Sakumoto M, Yoshida A, Setsu N, Kobayashi E, Kawai A, Kondo T. Establishment and characterization of a patient-derived cancer model of undifferentiated pleomorphic sarcoma. Tiss. Cult. Res. Commun. 37: 1–13 (2018)

Oyama R, Takahashi M, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Yoshida A, Endo M, Kawai A, Kondo T. Establishment and characterization of patient-derived xenograft and its cell line of primary leiomyosarcoma of bone. In Vitro Cell Dev Biol Anim. 2018 Jun;54(6):458-467. doi: 10.1007/s11626-018-0258-2. Epub 2018 May 29.

Sakumoto M, Takahashi M, Oyama R, Takai Y, Kito F, Shiozawa K, Qiao Z, Yoshida A, Endo M, Kawai A, Kondo T. Establishment and proteomic characterization of NCC-LMS1-C1, a novel cell line of primary leiomyosarcoma in the bone. Jap J Clin Oncol. 2017 Oct 1;47(10):954-961.

Oyama R, Takahashi M, Kito F, Sakumoto M, Takai Y, Kumiko S, Qiao Z, Toki S, Tanzawa Y, Yoshida A, Kawai A, Kondo T. Establishment and characterization of patient-derived pleomorphic rhabdomyosarcoma models. Tiss. Cult. Res. Commun. 2019;38(1)1-12.

Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15.

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, Yoshida A, Kawai A, Kondo T. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018 May;54(5):392-399. doi:  10.1007/s11626-018-0237-7. Epub 2018 Apr 6.

Sakumoto M, Oyama R, Takahashi M, Takai Y, Kito F, Shiozawa K, Qiao Z, Endo M, Yoshida A, Kawai A, Kondo T. Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines. In Vitro Cell Dev Biol Anim. 2018 Feb;54(2):163-176.

Kito F, Oyama R, Sakumoto M, Shiozawa K, Qiao Z, Toki S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma. Hum Cell. 2019 Feb 8. doi: 10.1007/s13577-018-00233-1. PubMed PMID: 30737712.

Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC-DUX4 sarcoma xenografts and cell lines. Sci Rep.2017 Jul 5;7(1):4712.

Oyama R, Kito F, Qiao Z, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T. Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1. In Vitro Cell Dev Biol Anim. 2019 Jan;55(1):62-73. doi: 10.1007/s11626-018-0305-z. PubMed PMID: 30411273.

MPNST 論文投稿中

2019年8月6日 NCC-SS1-C1、NCC-SS2-C1、NCC-UPS-C1

滑膜肉腫と未分化多型肉腫の細胞株を、National Taiwan University Hospital のTom Wei-Wu Chen 博士へ提供しました。

文献
Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15. PubMed PMID: 29450702.

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, Yoshida A, Kawai A,Kondo T. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018 May;54(5):392-399. doi: 10.1007/s11626-018-0237-7. Epub 2018 Apr 6. PubMed PMID: 29626278.

Takai Y, Oyama R, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Nakajima K, Takahashi M. Yoshida A, Nokitaka S, Kobayashi E, Kawai A. Kondo T. Establishment and characterization of cell line of undifferentiated pleomorphic sarcoma. Tiss. Cult. Res. Commun. 36: 41–48 (2017)

2019年6月27日 NCC-dCS1-C1

脱分化型軟骨肉腫の細胞株を、九州大学整形外科の遠藤誠先生へ提供しました。

文献
Oyama R, Kito F, Takahashi M, Sakumoto M, Shiozawa K, Qiao Z, Noguchi R, Kubo T, Toki S, Nakatani F, Yoshida A, Kawai A, Kondo T. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1. Hum Cell. 2019 Feb 8. doi: 10.1007/s13577-018-00232-2. [Epub ahead of print] PubMed PMID: 30737713.

2019年5月8日 NCC-ES1‐C1

ユーイング腫瘍の細胞株を、岡山大学整形外科の中田英二先生へ提供しました。

文献
Oyama R, Kito F, Qiao Z, Sakumoto M, Noguchi R, Takahashi M, Toki S, Tanzawa Y, Yoshida A, Kawai A, Kondo T. Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1. In Vitro Cell Dev Biol Anim. 2018 Dec;54(10):770-778. doi: 10.1007/s11626-018-0302-2. Epub 2018 Oct 15. PubMed PMID: 30324244.

2019年5月7日 NCC-CDS-X1‐C1、NCC-CDS1-X3-C1

CIC-DUX4陽性小細胞肉腫の細胞株を、University of CalgaryのJennifer Chan 博士へ提供しました。

文献
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486.

2019年4月17日 NCC-SS1-C1、NCC-SS2-C1

滑膜肉腫の細胞株を、山梨大学整形外科教室の市川二郎先生へ提供しました。

文献
Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15. PubMed PMID: 29450702.

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, Yoshida A, Kawai A,Kondo T. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018 May;54(5):392-399. doi: 10.1007/s11626-018-0237-7. Epub 2018 Apr 6. PubMed PMID: 29626278.

2019年3月20日 NCC-MFS1-C1

粘液線維肉腫の細胞株を、Chi Mei Medical CenterのChien-Feng Li 博士へ提供しました。

文献
Kito F, Oyama R, Sakumoto M, Shiozawa K, Qiao Z, Toki S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma. Hum Cell. 2019 Feb 8. doi: 10.1007/s13577-018-00233-1. [Epub ahead of print] PubMed PMID: 30737712.

2019年2月6日 NCC-CDS-X1‐C1、NCC-CDS1-X3-C1

CIC-DUX4陽性小細胞肉腫の細胞株を、Lausanne University HospitalのNicolò Riggi 博士へ提供しました。

文献
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. G eneration of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486.

2019年1月23日 NCC-OS1-C1

骨肉腫の細胞株を、岡山大学整形外科の宝田剛志先生に提供しました。

文献
Kito F, Oyama R, Sakumoto M, Takahashi M, Shiozawa K, Qiao Z, Sakamoto H,Hirose T, Setsu N, Yoshida A, Kawai A, Kondo T. Establishment and characterization of novel patient-derived osteosarcoma xenograft and cell line. In Vitro Cell Dev Biol Anim. 2018 Aug;54(7):528-536. doi: 10.1007/s11626-018-0274-2. Epub 2018 Jun 25. PubMed PMID: 29943355.

2019年1月5日 NCC-DFSP1-C1、NCC-DFSP2-C1

皮膚線維肉腫の細胞株を樹立し論文にて発表しました。

文献
Oyama R, Kito F, Qiao Z, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T. Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1. In Vitro Cell Dev Biol Anim. 2019 Jan;55(1):62-73. doi: 10.1007/s11626-018-0305-z. Epub 2018 Nov 8. PubMed PMID: 30411273.

2018年12月17日 NCC-SS1-C1、NCC-SS2-C1

滑膜肉腫の細胞株を、Roswell Park Comprehensive Cancer CenterのIrwin H. Gelman博士へ提供しました。

文献
Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15. PubMed PMID: 29450702.

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, Yoshida A, Kawai A,Kondo T. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018 May;54(5):392-399. doi: 10.1007/s11626-018-0237-7. Epub 2018 Apr 6. PubMed PMID: 29626278.

2018年12月12日 NCC-CDS-X1‐C1、NCC-CDS1-X3-C1

CIC-DUX4陽性小細胞肉腫の細胞株を、Dana-Farber Cancer InstituteのSamuel Abbou博士へ提供しました。

文献
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486.

2018年12月7日 NCC-SS1-C1、NCC-SS2-C1

滑膜肉腫の細胞株を、国立がん研究センター研究所・造血器腫瘍研究分野の中川亮先生に提供しました。

文献
Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15. PubMed PMID: 29450702.

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, Yoshida A, Kawai A,Kondo T. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018 May;54(5):392-399. doi: 10.1007/s11626-018-0237-7. Epub 2018 Apr 6. PubMed PMID: 29626278.

2018年11月20日 NCC-CDS-X1‐C1、NCC-CDS1-X3-C1

CIC-DUX4陽性小細胞肉腫の細胞株を、Lausanne University HospitalのNicolò Riggi博士へ提供しました。

文献
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486.

2018年11月14日 NCC-UPS1-C1、NCC-UPS2-C1

未分化多型肉腫の細胞株を、鹿児島大学運動機能修復学・整形外科の瀬戸口啓夫先生へ提供しました。

文献
Takai Y, Oyama R, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Nakajima K, Takahashi M. Yoshida A, Nokitaka S, Kobayashi E, Kawai A. Kondo T. Establishment and characterization of cell line of undifferentiated pleomorphic sarcoma. Tiss. Cult. Res. Commun. 36: 41–48 (2017)

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T.Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1,derived from a patient with undifferentiated pleomorphic sarcoma. In Vitro Cell Dev Biol Anim. 2018 Mar;54(3):257-263. doi: 10.1007/s11626-018-0229-7. Epub 2018 Jan 22. PubMed PMID: 29359268.

2018年11月12日 NCC-UPS1-C1、NCC-UPS2-C1

未分化多型肉腫の細胞株を、岡山大学整形外科の中田英二先生へ提供しました。

文献
Takai Y, Oyama R, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Nakajima K, Takahashi M. Yoshida A, Nokitaka S, Kobayashi E, Kawai A. Kondo T. Establishment and characterization of cell line of undifferentiated pleomorphic sarcoma. Tiss. Cult. Res. Commun. 36: 41–48 (2017)

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T.Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1,derived from a patient with undifferentiated pleomorphic sarcoma. In Vitro Cell Dev Biol Anim. 2018 Mar;54(3):257-263. doi: 10.1007/s11626-018-0229-7. Epub 2018 Jan 22. PubMed PMID: 29359268.

2018年10月9日 NCC-CCS1B-C1、NCC-CCS1B-X2-C1、NCC-CCS1-X4-C1

明細胞肉腫の細胞株を、Children's Cancer Therapy Development InstituteのCharles Keller博士へ提供しました。

文献
Sakumoto M, Oyama R, Takahashi M, Takai Y, Kito F, Shiozawa K, Qiao Z, Endo M,Yoshida A, Kawai A, Kondo T. Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines. In Vitro Cell Dev Biol Anim. 2018 Feb;54(2):163-176. doi: 10.1007/s11626-017-0207-5. Epub 2017 Dec 1. PubMed PMID: 29197033.   

2018年9月18日 NCC-SS1-C1、NCC-SS2-C1

滑膜肉腫の細胞株を、がん研究会の旦慎吾先生へ提供しました。

文献
Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15. PubMed PMID: 29450702.

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, Yoshida A, Kawai A,Kondo T. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018 May;54(5):392-399. doi: 10.1007/s11626-018-0237-7. Epub 2018 Apr 6. PubMed PMID: 29626278.  

2018年9月6日 NCC-SS1-C1、NCC-SS2-C1

滑膜肉腫の細胞株を、国立がん研究センター研究所・細胞情報学分野の増田万里先生に提供しました。滑膜肉腫の研究に御使用とのことです。

文献
Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15. PubMed PMID: 29450702.

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, Yoshida A, Kawai A,Kondo T. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018 May;54(5):392-399. doi: 10.1007/s11626-018-0237-7. Epub 2018 Apr 6. PubMed PMID: 29626278.

2018年8月24日 NCC-CDS1-X1-C1、NCC-CDS1-X3-C1

CIC-DUX4陽性小細胞肉腫の細胞株を、Tel-Aviv Sourasky Medical CenterのDana Ronen博士へ提供しました。

文献
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486.

2018年8月22日 NCC-SS2-C1、NCC-CDS1-X1-C1、NCC-CDS1-X3-C1

滑膜肉腫、CIC-DUX4陽性小細胞肉腫の細胞株を、Nebraska Medical CenterのJulia Bridge博士へ提供しました。

文献
Oyama R, Takahashi M, Kito F, Sakumoto M, Takai Y, Shiozawa K, Qiao Z, Toki S, Tanzawa Y, Toshida A, Kawai A, Kondo T. Establishment and characterization of patient-derived pleomorphic rhabdomyosarcoma models.Tiss. Cult. Res. Commun. In press

Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486. 

2018年8月3日 NCC-SS1-C1、NCC-SS2-C1

滑膜肉腫の細胞株を、MerrimackのDaryl Drummond博士へ提供しました。

文献
Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15. PubMed PMID: 29450702.

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, Yoshida A, Kawai A,Kondo T. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018 May;54(5):392-399. doi: 10.1007/s11626-018-0237-7. Epub 2018 Apr 6. PubMed PMID: 29626278.

2018年6月7日 NCC-OS1-C1

骨肉腫の細胞株を樹立し論文にて発表しました。

文献
Kito F, Oyama R, Sakumoto M, Takahashi M, Shiozawa K, Qiao Z, Sakamoto H,Hirose T, Setsu N, Yoshida A, Kawai A, Kondo T. Establishment and characterization of novel patient-derived osteosarcoma xenograft and cell line. In Vitro Cell Dev Biol Anim. 2018 Aug;54(7):528-536. doi: 10.1007/s11626-018-0274-2. Epub 2018 Jun 25. PubMed PMID: 29943355.  

2018年4月24日 NCC-SS1-C1、NCC-SS2-C1、NCC-CDS1-X1-C1, NCC-CDS1-X3-C1

滑膜肉腫およびCIC-DUX4陽性小細胞肉腫の細胞株を、Hudson Alpha Institute for BiotechnologyのLe Su博士へ提供しました。

文献
Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15. PubMed PMID: 29450702.

Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, Yoshida A, Kawai A,Kondo T. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018 May;54(5):392-399. doi: 10.1007/s11626-018-0237-7. Epub 2018 Apr 6. PubMed PMID: 29626278.

Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486.

2018年4月12日 NCC-LMS1-X3-C1

平滑筋肉腫の細胞株を樹立し論文にて発表しました。

文献
Oyama R, Takahashi M, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Yoshida A, Endo M, Kawai A, Kondo T. Establishment and characterization of patient-derived xenograft and its cell line of primary leiomyosarcoma of bone. In Vitro Cell Dev Biol Anim. 2018 Jun;54(6):458-467. doi: 10.1007/s11626-018-0258-2. Epub 2018 May 29. PubMed PMID: 29845452. 

2018年4月6日 NCC-pRMS1-C1

横紋筋肉腫の細胞株を樹立し論文にて発表しました。

文献
Oyama R, Takahashi M, Kito F, Sakumoto M, Takai Y, Shiozawa K, Qiao Z, Toki S, Tanzawa Y, Toshida A, Kawai A, Kondo T. Establishment and characterization of patient-derived pleomorphic rhabdomyosarcoma models.Tiss. Cult. Res. Commun. In press

2018年3月12日 NCC-LMS1-C1、NCC-LMS1-X3-C1、NCC-UPS1-C1、NCC-UPS1-X3-C1、NCC-CCS1B-C1、NCC-CCS1B-X2-C1、NCC-CCS1-X4-C1、NCC-CDS1-X1-C1、NCC-CDS1-X3-C1、NCC-pRMS1-C1、NCC-pRMS1-X4-C1、NCC-MPNST3-C1、NCC-MPNST3-X2-C1

平滑筋肉腫、未分化多型肉腫、明細胞肉腫、CIC-DUX4陽性小細胞肉腫、類上皮多型肉腫、悪性末梢神経鞘腫瘍の細胞株を、東京大学医学部泌尿器科の田口慧先生へ提供しました。

文献

Sakumoto M, Takahashi M, Oyama R, Takai Y, Kito F, Shiozawa K, Qiao Z, Yoshida A, Endo M, Kawai A, Kondo T. Establishment and proteomic characterization of NCC-LMS1-C1, a novel cell line of primary leiomyosarcoma of the bone. Jpn J Clin Oncol. 2017 Oct 1;47(10):954-961. doi: 10.1093/jjco/hyx096. PubMed PMID:28981730.

Oyama R, Takahashi M, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Yoshida A, Endo M, Kawai A, Kondo T. Establishment and characterization of patient-derived xenograft and its cell line of primary leiomyosarcoma of bone. In Vitro Cell Dev Biol Anim. 2018 Jun;54(6):458-467. doi: 10.1007/s11626-018-0258-2. Epub 2018 May 29.

Takai Y, Oyama R, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Nakajima K, Takahashi M. Yoshida A, Nokitaka S, Kobayashi E, Kawai A. Kondo T. Establishment and characterization of cell line of undifferentiated pleomorphic sarcoma. Tiss. Cult. Res. Commun. 2017 36: 41–48

Kito F, Oyama R, Takahashi M, Shiozawa K, Sakumoto M, Yoshida A, Setsu N, Kobayashi E, Kawai A, Kondo T. Establishment and characterization of a patient-derived cancer model of undifferentiated pleomorphic sarcoma. Tiss. Cult. Res. Commun. 2018 37: 1–13

Sakumoto M, Oyama R, Takahashi M, Takai Y, Kito F, Shiozawa K, Qiao Z, Endo M,Yoshida A, Kawai A, Kondo T. Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines. In Vitro Cell Dev Biol Anim. 2018 Feb;54(2):163-176. doi: 10.1007/s11626-017-0207-5. Epub 2017 Dec 1. PubMed PMID: 29197033.

Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486.

Oyama R, Takahashi M, Kito F, Sakumoto M, Takai Y, Kumiko S, Qiao Z, Toki S, Tanzawa Y, Yoshida A, Kawai A, Kondo T. Establishment and characterization of patient-derived pleomorphic rhabdomyosarcoma models. Tiss. Cult. Res. Res. Commun. In press

2018年1月25日 NCC-SS2-C1

滑膜肉腫の細胞株を樹立し論文にて発表しました。

文献
Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, Yoshida A, Kawai A, Kondo T. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018 May;54(5):392-399. doi: 10.1007/s11626-018-0237-7. Epub 2018 Apr 6

2018年1月9日 NCC-SS1-C1

滑膜肉腫の細胞株を樹立し論文にて発表しました。

文献
Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15. PubMed PMID: 29450702.

2018年1月5日 NCC-UPS2-C1

未分化多型肉腫の細胞株を樹立し論文にて発表しました。

文献
Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T.Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1,derived from a patient with undifferentiated pleomorphic sarcoma. In Vitro Cell Dev Biol Anim. 2018 Mar;54(3):257-263. doi: 10.1007/s11626-018-0229-7. Epub 2018 Jan 22. PubMed PMID: 29359268.

2017年11月13日 NCC-UPS1-C1

未分化多型肉腫の細胞株を樹立し論文にて発表しました。

文献
Takai Y, Oyama R, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Nakajima K, Takahashi M. Yoshida A, Nokitaka S, Kobayashi E, Kawai A. Kondo T. Establishment and characterization of cell line of undifferentiated pleomorphic sarcoma. Tiss. Cult. Res. Commun. 36: 41–48 (2017)

2017年10月10日 NCC-CCS1B-C1、NCC-CCS1B-X2-C1、NCC-CCS1-X4-C1

明細胞肉腫の細胞株を樹立し論文にて発表しました。

文献
Sakumoto M, Oyama R, Takahashi M, Takai Y, Kito F, Shiozawa K, Qiao Z, Endo M,Yoshida A, Kawai A, Kondo T. Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines. In Vitro Cell Dev Biol Anim. 2018 Feb;54(2):163-176. doi: 10.1007/s11626-017-0207-5. Epub 2017 Dec 1. PubMed PMID: 29197033.

2017年7月3日 NCC-LMS1-C1

滑膜肉腫の細胞株を樹立し論文にて発表しました。

文献
Sakumoto M, Takahashi M, Oyama R, Takai Y, Kito F, Shiozawa K, Qiao Z, Yoshida A, Endo M, Kawai A, Kondo T. Establishment and proteomic characterization of NCC-LMS1-C1, a novel cell line of primary leiomyosarcoma of the bone. Jpn J Clin Oncol. 2017 Oct 1;47(10):954-961. doi: 10.1093/jjco/hyx096. PubMed PMID:28981730.

2017年5月22日 NCC-CDS1-X1-C1, NCC-CDS1-X3-C1

CIC-DUX4を有する細胞株を樹立し論文にて発表しました。

 文献
Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486.